65 /100
HIGH RISK
Score updated May 30, 2026

ZVSA — ZyVersa Therapeutics, Inc. Dilution Risk Tracker

Track ZVSA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ZVSA — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
95
📊 Float Risk
15
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
53%
🔄 Reverse Split 70%
• 50-day avg $0.20 below $1 exchange minimum
• Only 2 months cash — financial pressure
💰 Capital Raise 55%
• Critical: only 1.7 months cash remaining
📉 Score Deterioration 10%
• Score in HIGH risk zone (65/100)
🔔 Track ZVSA — Get forecast alerts →

💹 Market Data

Market Cap$1.66M
Shares Outstanding8.10M
Float7.68M
Cash$302.7K
Debt$1.20M
Short InterestN/A

🏛 Institutional Holdings

1 institutional holders · 7 shares
#1 Guerra Advisors Inc 7 shares

📉 Short Interest

Short Interest165.6K
Days to Cover8.2
% of Float2.2%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 08, 2025
xbrl XBRL CONVERTIBLE Dec 12, 2022
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track ZVSA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ZVSA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: BATL BRN CDIO CDT CNTMD
🔬 More Research for ZVSA
📊 ZVSA FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ZVSA Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.